Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig W Lindsley

Showing results (11-20 of 742) with videos related to

Pageof 75
Sort By:
ACS Chemical Neuroscience|December 22, 2012
ACS Chemical Neuroscience and neuroscience drug discovery as 2012 comes to a closeCraig W Lindsley
ACS Chemical Neuroscience|July 18, 2013
A new impact factor and new directions for ACS Chemical NeuroscienceCraig W Lindsley
Current Topics in Medicinal Chemistry|February 26, 2010
The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 updateCraig W Lindsley
ACS Chemical Neuroscience|April 18, 2019
NeuroChat with Professor Steven TownsendCraig W Lindsley
ACS Chemical Neuroscience|November 16, 2017
Embarking on a 5 Year Journey to Highlight Genetic and Rare Diseases of the Central Nervous SystemCraig W Lindsley
Current Topics in Medicinal Chemistry|August 13, 2008
Molecule of the monthCraig W Lindsley
ACS Chemical Neuroscience|September 21, 2017
Emerging Data Strengthens the Argument That the Microbiome Is the Fifth Horseman of the Drug Discovery ApocalypseCraig W Lindsley
ACS Chemical Neuroscience|July 19, 2018
2018: A New Impact Factor and an Expanded Cast of Associate EditorsCraig W Lindsley
ACS Chemical Neuroscience|April 19, 2018
Genetic and Rare Disease of the CNS. Part II: Holoprosencephaly (HPE)Craig W Lindsley
ACS Chemical Neuroscience|March 22, 2018
Call for Papers: Allosteric Modulators of Drug Targets-Special Issue for 2019Craig W Lindsley
Pageof 75

Showing results (11-20 of 742) with videos related to

Sort By:
Pageof 75
ACS Chemical Neuroscience|December 22, 2012
ACS Chemical Neuroscience and neuroscience drug discovery as 2012 comes to a closeCraig W Lindsley
ACS Chemical Neuroscience|July 18, 2013
A new impact factor and new directions for ACS Chemical NeuroscienceCraig W Lindsley
Current Topics in Medicinal Chemistry|February 26, 2010
The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 updateCraig W Lindsley
ACS Chemical Neuroscience|April 18, 2019
NeuroChat with Professor Steven TownsendCraig W Lindsley
ACS Chemical Neuroscience|November 16, 2017
Embarking on a 5 Year Journey to Highlight Genetic and Rare Diseases of the Central Nervous SystemCraig W Lindsley
Current Topics in Medicinal Chemistry|August 13, 2008
Molecule of the monthCraig W Lindsley
ACS Chemical Neuroscience|September 21, 2017
Emerging Data Strengthens the Argument That the Microbiome Is the Fifth Horseman of the Drug Discovery ApocalypseCraig W Lindsley
ACS Chemical Neuroscience|July 19, 2018
2018: A New Impact Factor and an Expanded Cast of Associate EditorsCraig W Lindsley
ACS Chemical Neuroscience|April 19, 2018
Genetic and Rare Disease of the CNS. Part II: Holoprosencephaly (HPE)Craig W Lindsley
ACS Chemical Neuroscience|March 22, 2018
Call for Papers: Allosteric Modulators of Drug Targets-Special Issue for 2019Craig W Lindsley
Pageof 75